Bachem Holding Logo
CH0012530207
914589
BANB.SW

Bachem Holding

Caricamento quotazioni...

Previsioni

Non sono disponibili dati degli analisti per questa azienda.


  • BACHEM: 10-year investment would have returned a 402.74% gain

    Ten years ago the BACHEM share closed at CHF 14.97; with the closing price of CHF 75.25 on 14 August 2026, an investment of CHF 10,000 would be worth CHF 50,274.35 today, equivalent to a gain of 402.74 percent. BACHEM's market capitalization was most recently CHF 5.63 billion. The calculation does not take stock splits and dividends into account. » Altro su finanzen.net


  • BACHEM surpasses analysts' expectations in H1 2026 thanks to expansion of production capacities

    BACHEM reports revenue of CHF 326.4m for the first half of 2026 (+4.3% or +7.3% in local currency) and a net profit of CHF 50.3m, beating estimates. EBITDA fell 9% to CHF 82.8m and the margin declined to 25.4%; charges arose from start‑up costs of the new "Gebäude K" plant in Bubendorf. BACHEM invested CHF 148.4m in H1 and confirms full‑year investments of CHF 350–400m as well as a revenue growth target of 35–40% for 2026. At full capacity of the new plants, a markedly better second half and an EBITDA margin in the low thirties in local currency are expected. Boris Corpataux will become chief commercial officer and a member of the corporate executive committee effective 1 August 2026. » Altro su finanzen.net


  • BACHEM: one-year return of 0.81% on a CHF 10,000 investment

    Someone who had invested CHF 10,000 in BACHEM stock a year ago would have CHF 10,080.59 today, representing an increase of 0.81%. The closing price is CHF 75.05 and the market capitalization is around CHF 5.62 billion. Stock splits and dividends are not included in the calculation. » Altro su finanzen.net

Nel 2024, Bachem Holding ha già distribuito +0,75 di dividendi. L'ultimo pagamento è avvenuto a aprile 2024.

Dati finanziari dell'azienda

Nell'ultimo trimestre, Bachem Holding ha registrato ricavi pari a +353,66 Mio e un utile netto di +54,46 Mio
(EUR) giu 2026
YoY
Ricavi +353,66 Mio -
Utile lordo +88,46 Mio -
Utile netto +54,46 Mio -
EBITDA +89,12 Mio -

Dati fondamentali

Metrica Valore
Capitalizzazione di mercato
+6,09 Mrd
Numero di azioni
74,94 Mio
Massimo/minimo a 52 settimane
+88,85 - +51,78
Dividendi No
Beta
0,8
Rapporto P/E
+38,24
Rapporto PEG
+3,42
Rapporto P/B
+3,95
Rapporto P/S
+8,05

Profilo aziendale

Die Bachem Holding AG liefert Produkte für die Forschung, die klinische Entwicklung und die kommerzielle Anwendung an Pharma- und Biotechnologieunternehmen weltweit. Das Unternehmen befasst sich mit der Entwicklung, Produktion und regulatorischen Unterstützung von peptidischen pharmazeutischen Wirkstoffen, wie Peptid- und Oligonukleotid-NCEs (New Chemical Entities). Darüber hinaus bietet es kommerzielle NCEs und Generika sowie Dienstleistungen in den Bereichen Projektmanagement, Qualität und Regulierung, Analytik, Produktion nach guter Herstellungspraxis, Produktion in Forschungsqualität sowie Lieferung und vertikale Integration an. Das Unternehmen wurde 1971 gegründet und hat seinen Hauptsitz in Bubendorf, Schweiz. Die Bachem Holding AG ist eine Tochtergesellschaft der Ingro Finanz AG.

Nome
Bachem Holding
CEO
Anne-Kathrin Stoller
Sede centrale Bubendorf, bl
Svizzera
Sito web
Settore
Sanità
Industria
Prodotti farmaceutici
Quotazione in borsa
17/07/1998
Dipendenti 2.725

Simboli di borsa

Borsa Simbolo
SIX
BANB.SW
🍪

Parqet  usa i cookie. Scopri di più